Canada: Apotex Sought To Enter The Market With Its Generic Version Of Travoprost (Intellectual Property Weekly Abstracts Bulletin – Week Of August 18)

NOC Cases

Invalidity Allegations re Anticipation and Obviousness found Justified

Alcon Canada Inc. v. Apotex Inc. , 2014 FC 699<</p>

Drug: travoprost

In this case, Apotex sought to enter the market with its generic version of travoprost. The Court dismissed the proceeding on the basis that Apotex' allegations as to anticipation and obviousness were held to be justified. The Court construed the claims at issue to claim the use of a compound containing a therapeutically effective amount of travoprost for the treatment of glaucoma and ocular hypertension; and the use of a topical opthalmic composition for the treatment of glaucoma and ocular hypertension.

The Court held that the patent at issue was not a selection patent, as one of the hallmarks of a selection patent is a clear statement of the promise of the special advantages of the selected compound over the genus. In this case, the Court held that although some classic selection language is used, the claims as construed do not promise more than therapeutic effectiveness in the treatment of glaucoma and ocular hypertension. Since the promise is only to be useful or to provide a therapeutically effective treatment for glaucoma, then it has not asserted any special advantages, and will not be characterized as a selection patent.

The Court considered the inventive concept and the promise of the patent, and held that this promise was soundly predicted. The Court then held that the anticipation allegations were justified, as an exact description is not required in the test for anticipation, and travoprost was encompassed by the compounds of one of the pieces of prior art, although it was not specifically named or made. The Court dismissed Alcon's argument that travoprost was carved out of the previous document. The Court also held that the allegations as to obviousness were justified.


Court Grants Appeal: Decision of Registrar Set Aside

Hayabusa Fightwear Inc. v. Suzuki Motor Corporation , 2014 FC 784

This was an appeal of a decision of the Trade-marks Opposition Board refusing the trade-mark application made by Hayabusa Fightwear Inc. (the "Applicant"), seeking registration of the trade-mark HAYABUSA (the "Mark"). The refusal was made following the opposition of Suzuki Motor Corporation (the "Respondent") for registration of the Mark.

As background, the Applicant designs and sells specialized fightgear and fightwear, in the field of mixed martial arts. The Respondent has been using the registered trade-mark HAYABUSA in relation to motorcycles and fittings thereof, and in relation to caps (or hats) (although the HAYABUSA trade-mark of the Respondent (the "Cited Mark") is registered for use in association with motorcycles and fittings, but not in relation to caps).

The grounds of opposition were essentially related to non-conformity (pursuant to section 30 of the Act),non-registrability (confusion), not the person entitled to registration (confusion) and non-distinctiveness pursuant to section 2 of the Act. The Registrar dismissed one ground of opposition related to non-conformity, but largely sided with the Respondent on the others. The Registrar decided not to deal with the grounds of non-registrability and one of the non-conformity grounds (lack of statement in ordinary commercial terms).

On appeal, the Applicant filed additional affidavit evidence of its Co-President and CFO. As a result, the issues on the appeal were: (1) does the additional evidence materially affect the Registrar's decision for each individual ground of opposition? (2) was the Registrar's decision reasonable? and (3) can the Court decide the remaining grounds of opposition that the Opposition Board chose not to decide?

The Applicant argued that its new evidence would have materially affected the Registrar's decision since it would have addressed the evidentiary gaps raised by the Registrar itself, in particular regarding non-entitlement (regarding the channels of trade), and distinctiveness. The Court was not persuaded, noting that the supplementary affidavit evidence was not relevant and could not have materially affected the Registrar's decision.

With respect to the reasonableness of the Registrar's decision, the Court held that the different channels of trade for the products of the Applicant and the Respondent were a most crucial factor that should have tipped the balance in favour of the Applicant. The Court held that the Registrar could not reasonably conclude, on the basis of the evidence that was before her, that this factor was not sufficient to shift the balance of probabilities in favour
of the Applicant.

The Court also decided the remaining grounds of opposition that the Opposition Board chose not to decide, namely non-registrability and one of the non-conformity grounds (lack of statement in ordinary commercial terms). Both were dismissed, with brief reasons.

Therefore, the Court granted the appeal and set aside the decision of the Registrar.

Industry News

Health Canada has released a draft revised Guidance Document: Reconsiderat​ion of Decisions Issued for Human Drug Submissions for a 60-day consultation period. The Consultation is open until October 11, 2014.

The BLG Life Sciences Group has published LIFESIGNS: Life Sciences Legal Trends​ in Canada, a Report on Intellectual Property, Litigation, Corporate Commercial legal trends and industry developments in Canada.

About BLG

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions